Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 234

1.

Biosynthesis of heme O in intraerythrocytic stages of Plasmodium falciparum and potential inhibitors of this pathway.

Simão-Gurge RM, Wunderlich G, Cricco JA, Cubillos EFG, Doménech-Carbó A, Cebrián-Torrejón G, Almeida FG, Cirulli BA, Katzin AM.

Sci Rep. 2019 Dec 17;9(1):19261. doi: 10.1038/s41598-019-55506-y.

2.

[Radiation Exposition of preparations of radiopharmaceuticals in routinely use, measured with optical-stimulated luminescence (OSL) dosimeters].

Wunderlich G, Freudenberg R, Hartmann H, Herrling P, Kotzerke J.

Nuklearmedizin. 2019 Dec;58(6):470-473. doi: 10.1055/a-1031-9251. Epub 2019 Nov 13. German.

PMID:
31724146
3.

A multilamellar nanoliposome stabilized by interlayer hydrogen bonds increases antimalarial drug efficacy.

Fotoran WL, Müntefering T, Kleiber N, Miranda BNM, Liebau E, Irvine DJ, Wunderlich G.

Nanomedicine. 2019 Nov;22:102099. doi: 10.1016/j.nano.2019.102099. Epub 2019 Oct 21.

PMID:
31648039
4.

A theranostic PSMA ligand for PET imaging and retargeting of T cells expressing the universal chimeric antigen receptor UniCAR.

Arndt C, Feldmann A, Koristka S, Schäfer M, Bergmann R, Mitwasi N, Berndt N, Bachmann D, Kegler A, Schmitz M, Puentes-Cala E, Soto JA, Ehninger G, Pietzsch J, Liolios C, Wunderlich G, Kotzerke J, Kopka K, Bachmann M.

Oncoimmunology. 2019 Sep 7;8(11):1659095. doi: 10.1080/2162402X.2019.1659095. eCollection 2019.

5.

68Ga-RM2 PET in PSMA- positive and -negative prostate cancer patients.

Hoberück S, Michler E, Wunderlich G, Löck S, Hölscher T, Froehner M, Braune A, Ivan P, Seppelt D, Zöphel K, Kotzerke J.

Nuklearmedizin. 2019 Sep;58(5):352-362. doi: 10.1055/a-0990-8898. Epub 2019 Aug 23.

PMID:
31443113
6.

Correction to: Novel mutations in KMT2B offer pathophysiological insights on childhood-onset progressive dystonia.

Dafsari HS, Sprute R, Wunderlich G, Daimagüler HS, Karaca E, Contreras A, Becker K, Schulze-Rhonhof M, Kiening K, Karakulak T, Kloss M, Horn A, Pauls A, Nürnberg P, Altmüller J, Thiele H, Assmann B, Koy A, Cirak S.

J Hum Genet. 2019 Oct;64(10):1051-1054. doi: 10.1038/s10038-019-0644-y.

PMID:
31388109
7.

Recombinant proteins of Plasmodium malariae merozoite surface protein 1 (PmMSP1): Testing immunogenicity in the BALB/c model and potential use as diagnostic tool.

Elizardez YB, Fotoran WL, Junior AJG, Curado I, Junior NK, Monteiro EF, Romero Neto I, Wunderlich G, Kirchgatter K.

PLoS One. 2019 Jul 25;14(7):e0219629. doi: 10.1371/journal.pone.0219629. eCollection 2019.

8.

Rapid alterations in MR imaging in MELAS syndrome.

Doppler CEJ, Kabbasch C, Fink GR, Lehmann HC, Wunderlich G.

Pract Neurol. 2019 Oct;19(5):447-448. doi: 10.1136/practneurol-2019-002266. Epub 2019 Jul 10. No abstract available.

PMID:
31292237
9.

[Radio- and photosensitization of plasmid DNA by DNA binding ligand propidium iodide: Investigation of Auger electron induction and detection of Cherenkov-emission].

Kotzerke J, Runge R, Götze P, Wunderlich G, Enghardt W, Freudenberg R.

Nuklearmedizin. 2019 Aug;58(4):319-327. doi: 10.1055/a-0953-1157. Epub 2019 Jun 27. German.

PMID:
31250407
10.

Novel mutations in KMT2B offer pathophysiological insights into childhood-onset progressive dystonia.

Dafsari HS, Sprute R, Wunderlich G, Daimagüler HS, Karaca E, Contreras A, Becker K, Schulze-Rhonhof M, Kiening K, Karakulak T, Kloss M, Horn A, Pauls A, Nürnberg P, Altmüller J, Thiele H, Assmann B, Koy A, Cirak S.

J Hum Genet. 2019 Aug;64(8):803-813. doi: 10.1038/s10038-019-0625-1. Epub 2019 Jun 5. Erratum in: J Hum Genet. 2019 Aug 6;:.

PMID:
31165786
11.

Dual-time-point 64 Cu-PSMA-617-PET/CT in patients suffering from prostate cancer.

Hoberück S, Wunderlich G, Michler E, Hölscher T, Walther M, Seppelt D, Platzek I, Zöphel K, Kotzerke J.

J Labelled Comp Radiopharm. 2019 Jun 30;62(8):523-532. doi: 10.1002/jlcr.3745. Epub 2019 Jun 17.

PMID:
31042811
12.

Pharmacokinetics of Single Doses of BI 425809 in Healthy Chinese and Japanese Subjects: A Randomized Study.

Tsuda Y, Ugai H, Wunderlich G, Shin JG.

Clin Ther. 2019 May;41(5):961-971. doi: 10.1016/j.clinthera.2019.03.014. Epub 2019 Apr 17.

PMID:
31005336
13.
14.

A novel third-generation TSH receptor antibody (TRAb) enzyme-linked immunosorbent assay based on a murine monoclonal TSH receptor-binding antibody.

Roggenbuck JJ, Veiczi M, Conrad K, Schierack P, Wunderlich G, Kotzerke J, Roggenbuck D, Zöphel K.

Immunol Res. 2018 Dec;66(6):768-776. doi: 10.1007/s12026-018-9062-z.

PMID:
30684216
15.

Nano-multilamellar lipid vesicles (NMVs) enhance protective antibody responses against Shiga toxin (Stx2a) produced by enterohemorrhagic Escherichia coli strains (EHEC).

Rodrigues-Jesus MJ, Fotoran WL, Cardoso RM, Araki K, Wunderlich G, Ferreira LCS.

Braz J Microbiol. 2019 Jan;50(1):67-77. doi: 10.1007/s42770-018-0035-0. Epub 2018 Dec 6.

16.

Different Radionuclides in DOTA-EB-TATE Effect Different Uptake in Somatostatin Receptor-Positive HEK293 Cells.

Kotzerke J, Runge R, Braune A, Wunderlich G.

J Nucl Med. 2019 Mar;60(3):436. doi: 10.2967/jnumed.118.220707. Epub 2018 Nov 15. No abstract available.

17.

Evaluation of Pharmacokinetics and Pharmacodynamics of BI 425809, a Novel GlyT1 Inhibitor: Translational Studies.

Rosenbrock H, Desch M, Kleiner O, Dorner-Ciossek C, Schmid B, Keller S, Schlecker C, Moschetti V, Goetz S, Liesenfeld KH, Fillon G, Giovannini R, Ramael S, Wunderlich G, Wind S.

Clin Transl Sci. 2018 Nov;11(6):616-623. doi: 10.1111/cts.12578. Epub 2018 Aug 23.

18.

Long term history of a congenital core-rod myopathy with compound heterozygous mutations in the Nebulin gene.

Wunderlich G, Brunn A, Daimagüler HS, Bozoglu T, Fink GR, Lehmann HC, Weis J, Cirak S.

Acta Myol. 2018 Jun 1;37(2):121-127. eCollection 2018 Jun.

19.

Late onset necrotizing autoimmune myopathy 1 year after cessation of statin treatment.

Balke M, Brunn A, Claeys KG, Fink GR, Wunderlich G.

Acta Neurol Belg. 2019 Sep;119(3):487-489. doi: 10.1007/s13760-018-0985-x. Epub 2018 Jul 14. No abstract available.

PMID:
30008064
20.

[Congenital myasthenic syndromes in adulthood : Challenging, rare but treatable].

Wunderlich G, Abicht A, Brunn A, Daimagüler HS, Schroeter M, Fink GR, Lehmann HC, Cirak S.

Nervenarzt. 2019 Feb;90(2):148-159. doi: 10.1007/s00115-018-0562-9. Review. German.

PMID:
29974128

Supplemental Content

Loading ...
Support Center